Mapping community pharmacy services in Brazil: a scoping review

Abstract The delivery of clinical pharmacy services has been growing in Brazilian community pharmacies, and it is necessary to have a comprehensive understanding of the topic. This scoping review aimed to provide an overview of Brazilian studies about clinical pharmacy services in community pharmacies. Original research articles, with no restriction of time, study design, or patient's health condition, were included. Searches were conducted in PubMed, Scopus, Web of Science, Scielo, and Lilacs. Two reviewers conducted the screening, full-text reading, and data extraction independently. ROB and ROBINS-I were used for the assessment of quality. Charts and tables were built to summarise the data. Seventy-two articles were included. A diversity of study designs, number of participants, terms used, and outcomes was found. São Paulo and Sergipe States had the highest number of studies (n=10). Pharmacists' interventions were not fully reported in 65% of studies, and most studies presented an unclear risk of bias. Studies were very diverse, impairing the comparisons between the results and hindering their reproducibility. This review suggests using guidelines and checklists for better structuration of pharmacists' interventions as well as reporting results and measuring fidelity in future research.

Consenso de farmacia clínica intensiva a nivel nacional / Consensus about the duties of pharmacists in intensive care units in Chile

In 2015, the directors of the Clinical Pharmacists Division of the Chilean Society of Intensive Care Medicine (SOCHIMI) organized a collaborative work along the country to define the minimum activities and duties that a pharmacist should perform in an Intensive Care Unit in Chile, according to the Ministry of Health and SOCHIMI guidelines and recommendations. This document summarizes the agreements on three priority areas of pharmacists' duties in intensive care: a) pharmacotherapy follow-up; b) pharmacological surveillance and security management of medications, and c) data recording and documentation. The recommendations collect the experiences from Chilean pharmacists along the country and provide information and support for future consensus for other specialties.

Patient safety and the value of pharmaceutical intervention in a cancer hospital / Segurança do paciente e o valor da intervenção farmacêutica em um hospital oncológico

ABSTRACT Objective To demonstrate economic impact of pharmaceutical evaluation in detection and prevention of errors in antineoplastic prescriptions. Methods This was an observational and retrospective study performed in a cancer hospital. From July to August 2016 pharmacists checked prescriptions of antineoplastic and adjuvant drugs. Drug-related problems observed were classified and analyzed concerning drug, pharmaceutical intervention, acceptability and characteristic of the error. In case of problem related to dose, we calculated a deviation percentage related with correct dose and value spent or saved. Data were analyzed using descriptive statistics with frequency and percentage. Results A total of 6,104 prescriptions and 12,128 medications were evaluated. Drug-related problems were identified in 274 (4.5%) prescriptions. Most of them was due to lack of information (n=117; 36.1%). Problems associated with dose accounted for 32.1% (n=98) of the total. In 13 cases (13.3%) ranging of prescribed dose was 50% greater than the correct dose. Intercepted drug-related problems provided savings of R$54.081,01 and expenses of R$20.863,36, therefore resulting in a positive balance of R$33.217,65. Each intervention promoted saving of R$126,78 with an acceptance rate of 98%. Main pharmaceutical interventions were information inclusion (n=117; 36.1%) and dose change (n=97; 29.9%). All errors were classified as error with no harm. Conclusion Simple actions such as prescription checking are able to identify and prevent drug-related problems, avoid financial losses and add immeasurable value to patient safety.

RESUMO Objetivo Demonstrar o impacto econômico da avaliação farmacêutica na detecção e na prevenção de erros em prescrições de antineoplásicos. Métodos Estudo observacional e retrospectivo realizado em um hospital oncológico. De julho a agosto de 2016, prescrições contendo antineoplásicos e fármacos adjuvantes ao tratamento foram avaliadas por farmacêuticos. Os problemas detectados relacionados a medicamentos foram classificados e analisados quanto ao medicamento, à intervenção farmacêutica, à aceitabilidade e à caracterização do erro. Quando o problema envolveu dose, calcularam-se a percentagem de desvio em relação à dose correta e o valor gasto ou economizado. Os dados foram analisados por estatística descritiva com aplicação de frequência e percentual. Resultados Foram avaliadas 6.104 prescrições e 12.128 medicamentos. Identificaram-se problemas relacionados a medicamentos em 274 (4,5%) prescrições, sendo a maioria causado por falta de informações (n=117; 36,1%). Quando reunidos, os problemas envolvendo dose representaram 32,1% (n=98) do total. Em 13 casos (13,3%), a variação da dose prescrita em relação à correta foi maior do que 50%. Os problemas relacionados a medicamentos interceptados representaram economia de R$54.081,01 e gastos de R$20.863,36, resultando em saldo positivo de R$33.217,65. Cada intervenção promoveu economia de R$126,78 com aceitabilidade de 98%. As principais intervenções foram inclusão de informações (n=117; 36,1%) e alteração de dose (n=97; 29,9%). Todos os erros foram considerados sem dano. Conclusão Ações simples de serem implantadas, como análise de prescrições, são capazes de identificar e prevenir problemas relacionados a medicamentos, evitar perdas financeiras e agregar imensurável valor na segurança do paciente.

Impact assessment of an automated drug-dispensing system in a tertiary hospital

OBJECTIVE: To evaluate the costs and patient safety of a pilot implementation of an automated dispensing cabinet in a critical care unit of a private tertiary hospital in São Paulo/Brazil. METHODS: This study considered pre- (January-August 2013) and post- (October 2013-October 2014) intervention periods. We considered the time and cost of personnel, number of adverse events, audit adjustments to patient bills, and urgent requests and returns of medications to the central pharmacy. Costs were evaluated based on a 5-year analytical horizon and are reported in Brazilian Reals (R$) and US dollars (USD). RESULTS: The observed decrease in the mean number of events reported with regard to the automated drug-dispensing system between pre- and post-implementation periods was not significant. Importantly, the numbers are small, which limits the power of the mean comparative analysis between the two periods. A reduction in work time was observed among the nurses and administrative assistants, whereas pharmacist assistants showed an increased work load that resulted in an overall 6.5 hours of work saved/day and a reduction of R$ 33,598 (USD 14,444) during the first year. The initial investment (R$ 206,065; USD 88,592) would have been paid off in 5 years considering only personnel savings. Other findings included significant reductions of audit adjustments to patient hospital bills and urgent requests and returns of medications to the central pharmacy. CONCLUSIONS: Evidence of the positive impact of this technology on personnel time and costs and on other outcomes of interest is important for decision making by health managers.

Interventions of the clinical pharmacist in an Intermediate Care Unit for elderly patients / Intervenções do farmacêutico clínico em uma Unidade de Cuidados Intermediários com foco no paciente idoso

ABSTRACT Objective To discuss the role of the clinical pharmacist in hospital care of critical elderly patients. Methods Critical patients aged 60 years and over admitted by the clinical staff to an Intermediate Care Unit were followed-up for 4 months regarding their drug therapies. Medical prescriptions were reviewed daily on the basis of patients' clinical conditions, with the view to identify opportunities for optimization of drug therapies, contributing to safer prescribing, reduced discomfort and correct and rational use of drugs. Results A total of 386 prescriptions were reviewed and 212 pharmaceutical interventions performed; 64.3% of prescriptions were classified as accepted with changes, 28.5% not accepted and 7.2% verbally accepted with no changes. Interventions included drug therapy indications, directions for dose adjustment, reduction of the use of potentially inappropriate medications for older patients, prescription adjustments, discontinuing unnecessary drugs, among others. Conclusion The significant number of interventions accepted by the healthcare staff supports the relevance of the clinical pharmacist as a member of the multiprofessional team, especially in care of the elderly.

RESUMO Objetivo Discutir o papel do farmacêutico clínico no cuidado hospitalar de pacientes críticos, idosos. Métodos Ao longo do período de 4 meses, foi realizado o acompanhamento farmacoterapêutico de pacientes críticos com 60 anos ou mais, admitidos pela equipe de Clínica Médica em uma Unidade de Cuidados Intermediários. Diariamente, foram realizadas avaliações das prescrições médicas, frente ao quadro clínico, a fim de encontrar oportunidades de otimização da farmacoterapia prescrita, contribuindo para a maior segurança da prescrição, a redução de desconfortos, e o uso correto e racional de medicamentos. Resultados Foram avaliadas 386 prescrições e realizadas 212 intervenções farmacêuticas, sendo 64,3% destas classificadas como aceitas com alteração na prescrição, 28,5% não aceitas e 7,2% aceitas verbalmente, porém sem alteração na prescrição. As intervenções envolviam indicações farmacoterapêuticas, orientações para ajustes de dose, redução do uso de medicamentos potencialmente inapropriados para idosos, ajustes de prescrição, suspensão de medicamentos desnecessários, entre outras. Conclusão O significativo número de intervenções aceitas pela equipe da saúde reforça o papel que o farmacêutico clínico tem a desempenhar na equipe multiprofissional, sobretudo quando direcionados ao cuidado de idosos.

Medicamentos orais de uma unidade hospitalar: adequação ao uso por cateteres enterais / Medicamentos orales de una unidad hospitalaria: adecuación al uso utilizando sondas gástricas / Oral drugs at a hospital unit: adequacy for use via enteral feeding tubes

RESUMO Objetivo: descrever o perfil de medicamentos orais padronizados em uma unidade hospitalar e verificar sua adequação quanto ao uso por cateteres enterais, de acordo com recomendações da literatura. Método: estudo descritivo, com dados sobre medicamentos coletados do Sistema de Dispensação do Serviço de Farmácia. As recomendações específicas para uso de tais medicamentos por cateteres enterais foram obtidas após busca em bases literárias, livros, manuais, guidelines e bulários. Resultados: dos 236 medicamentos orais dispensados, 86% estavam na forma sólida; destes, 32 eram "não trituráveis", havendo disponibilidade da forma líquida na instituição. Foram identificados 28 medicamentos com potenciais interações com a nutrição enteral. Sessenta porcento deles apresentavam recomendações específicas sobre sua administração por cateter enteral. Conclusão: a participação conjunta das equipes multidisciplinares de terapia nutricional e de assistência e a implementação de programas para treinamento contínuo constituem estratégias sugeridas para a prevenção de potenciais problemas na administração de medicamentos no espaço hospitalar.

RESUMEN Objetivo: describir el perfil de medicamentos orales estandarizados en una unidad hospitalaria y verificar su adecuación respecto del uso vía sondas gástricas, según recomendaciones de la literatura. Método: estudio descriptivo, con datos sobre medicamentos recolectados del Sistema de Dispensación del Servicio de Farmacia. Las recomendaciones específicas de uso por sondas gástricas fueron obtenidas por búsqueda en bases de literatura, libros, manuales, guidelines y vademécums. Resultados: De los 236 medicamentos orales dispensados, 86% se presentaban en forma sólida; de ellos, 32 eran "no triturables", existiendo disponibilidad de la forma líquida en la institución. Fueron identificados 28 medicamentos con potenciales interacciones con la nutrición enteral. El 60% incluía recomendaciones específicas sobre administración por sonda gástrica. Conclusión: la participación conjunta de equipos multidisciplinarios de terapia nutricional y de atención y la implementación de programas de capacitación permanente constituye estrategias sugeridas para prevenir potenciales problemas en administración de medicamentos en el ámbito hospitalario.

ABSTRACT Objective: to describe the profile of standardized oral drugs at a hospital unit and assess their adequacy for use via enteral feeding tubes, according to recommendations from the literature. Method: descriptive study, with data on drugs collected from the Pharmacy Service Dispensing System. Specific recommendations for the use of these drugs via enteral feeding tubes were found after searches in literary databases, books, manuals, guidelines and package insert collections. Results: among the 236 dispensed oral drugs, 86% were in solid form; of those, 32 were "non-crushable", with the liquid form available at the institution. Twenty-eight drugs with potential interactions with enteral nutrition were identified. Sixty percent of those presented specific recommendations on their administration via enteral feeding tube. Conclusion: the joint participation of multidisciplinary nutritional therapy and care teams and the implementation of programs for continuous training are suggested strategies for the prevention of potential problems in the administration of drugs in the hospital setting.

Patient attrition from the HIV antiretroviral therapy program at two hospitals in Haiti / Abandono del programa de tratamiento antirretrovírico de la infección por el VIH en pacientes de dos hospitales de Haití

OBJECTIVE: To identify factors associated with antiretroviral therapy (ART) attrition among patients initiating therapy in 2005-2011 at two large, public-sector department-level hospitals, and to inform interventions to improve ART retention. METHODS: This retrospective cohort study used data from the iSanté electronic medical record (EMR) system. The study characterized ART attrition levels and explored the patient demographic, clinical, temporal, and service utilization factors associated with ART attrition, using time-to-event analysis methods. RESULTS: Among the 2 023 patients in the study, ART attrition on average was 17.0 per 100 person-years (95% confidence interval (CI): 15.8-18.3). In adjusted analyses, risk of ART attrition was up to 89% higher for patients living in distant communes compared to patients living in the same commune as the hospital (hazard ratio: 1.89, 95%CI: 1.54-2.33; P < 0.001). Hospital site, earlier year of ART start, spending less time enrolled in HIV care prior to ART initiation, receiving a non-standard ART regimen, lacking counseling prior to ART initiation, and having a higher body mass index were also associated with attrition risk. CONCLUSIONS: The findings suggest quality improvement interventions at the two hospitals, including: enhanced retention support and transportation subsidies for patients accessing care from remote areas; counseling for all patients prior to ART initiation; timely outreach to patients who miss ART pick-ups; "bridging services" for patients transferring care to alternative facilities; routine screening for anticipated interruptions in future ART pick-ups; and medical case review for patients placed on non-standard ART regimens. The findings are also relevant for policymaking on decentralization of ART services in Haiti.

OBJETIVO: Determinar los factores asociados con el abandono del tratamiento antirretrovírico en los pacientes que iniciaron el tratamiento en el período del 2005 al 2011 en dos grandes hospitales públicos de nivel departamental, y fundamentar las intervenciones necesarias para mejorar la retención de los pacientes en el tratamiento. MÉTODOS: Este estudio retrospectivo de cohortes empleó los datos del sistema de registro médico electrónico iSanté. Se describieron los niveles de abandono del tratamiento y se exploraron los factores demográficos, clínicos, temporales y de utilización de los servicios que se asociaban con su abandono, usando métodos de análisis del tiempo trascurrido hasta un evento. RESULTADOS: El abandono del tratamiento entre los 2 023 pacientes incluidos en el estudio fue en promedio de 17,0 por 100 personas-años (intervalo de confianza (IC) de 95%: 15,8-18,3). En los análisis ajustados, el riesgo de abandono del tratamiento fue de hasta 89% mayor en los pacientes que vivían en comunas distantes, en comparación con los pacientes que vivían en la misma comuna en que se ubicaba el hospital (razón de riesgo: 1,89; IC de 95%: 1,54-2,33; P < 0,001). La ubicación del hospital, el inicio del tratamiento en un año calendario anterior, un menor tiempo de inclusión en el programa de atención a la infección por el VIH antes de iniciar el tratamiento, la administración de un régimen terapéutico no estándar, la falta de orientación antes de iniciar el tratamiento y un mayor índice de masa corporal también se asociaron con un riesgo más elevado de abandono. CONCLUSIONES: Los resultados sugieren algunas intervenciones de mejora de la calidad en ambos hospitales, entre ellas: un mayor apoyo a la retención y subsidios de transporte para los pacientes que acuden desde zonas remotas para ser atendidos; la orientación a todos los pacientes antes del inicio del tratamiento antirretrovírico; el contacto oportuno de los servicios con los pacientes que omiten alguna recogida de medicación; "servicios de conexión" para transferir la atención de los pacientes a otros establecimientos alternativos; el tamizaje sistemático de las interrupciones previstas en las próximas recogidas de medicación; y la revisión médica de los casos de pacientes que siguen un tratamiento no estándar. Estos hallazgos son también pertinentes en materia de formulación de políticas de descentralización de los servicios de tratamiento antirretrovírico en Haití.

Determinación de stock de medicamentos y productos médicos para tratamiento inicial en desastres utilizando la tecnica DELPHI en un Hospital del interior de la Provincia de Córdoba (Argentina) / Drugs and medical products stock determination for initial treatment in disaster situations using delphi technique in a hospital in the interior of the province of Cordoba (Argentina) / Determinação do estoque de medicamentos eprodutos médicos para tratamento inicial emdesastres empregando a técnica delphi em umhospital do interior da província de Córdoba (Argentina)

El objetivo de este trabajo fue determinar el stock de medicamentos y productos médicos para el tratamiento inicial de víctimas en masa en un hospital de la provincia de Córdoba (Argentina).Se utilizó la Técnica Delphi como método de consenso. Se solicitó la participación de 13 profesionales entre médicos y enfermeras del Hospital Dr. Arturo U. Illia de la ciudad de Alta Gracia, coordinados por una farmacéutica. Se realizaron 3 cuestionarios por medio de los cuales se arribó a la selección de los insumos necesarios para la atención de víctimas en masa para un plazo de 48 horas.Se determinaron dos listados finales con 25 medicamentos y 25 productos médicos, respectivamente.La utilización de esta técnica en la mencionada selección, agilizó el consenso en la toma de decisiones respecto a la inclusión de los insumos en cuestión.

The objective of this work was to determine the stock of drugs and medical products for the initial treatment of mass casualties at a hospital in the province of Córdoba (Argentina). Delphi Technique was used as the consensus method. Thirteen practitioners including physicians and nurses from Dr. Arturo U. Illia Hospital, in the city of Alta Gracia, were requested to participate, coordinated by a pharmacist. Three questionnaires were produced to come to a selection of the necessary products for mass casualty management during a 48-hour period. Two final lists were made with 25 drugs and 25 medical products, respectively. The use of this technique for the above mentioned selection accelerated consensus in decision making regarding the inclusion of the items in question

Drugs dispensed at the Division of Neonatology at University Hospital in Río Cuarto, Córdoba, Argentina / Medicamentos dispensados al Servicio de Neonatología de un hospital de Río Cuarto, Córdoba

Introduction. The objective was to analyze the number of drugs dispensed by the Pharmacy Department to the Neonatology Division, to find out if the use of these drugs is described on the package insert approved by the Administración Nacional de Medicamentos, Alimentos y Tecnología, ANMAT (Drug, Food and Technology Administration of Argentina) and to compare such information with that provided by Medical Associations and Commissions. Population and methods. Analytical, observational and retrospective study in which drugs were analyzed based on dosage units, costs and relevance in the 2011 annual budget. We analyzed the information found in ANMAT-approved label inserts, in the Neonatal Pharmacopeia of the Sociedad Argentina de Pediatría and in the Formularies of the Confederación Médica Argentina and the Comisión Nacional del Medicamento (National Medication Commission). Results. A total of 102 drugs (91 drug substances) were dispensed throughout 2011. Drugs most commonly supplied were: antiinfective agents for systemic use (24.51%), agents for the blood and blood forming organs, cardiovascular system, and nervous system (12.72% each). The total expenditure was ARS 263,285.52. Only 21 drugs accounted for 90.73% of the cost. Out of the 14 drugs in this group, only 1 had information related to its use in neonatology in all its labels (package inserts), only 4 in some of their product information and there was no information at all in any of the remaining 9 drugs. The Neonatal Pharmacopeia reported on 12 of the 14 drugs, while the Formularies made a reference to 9 of the 14 drugs. Conclusions. The most widely used drugs were antiinfectives for systemic use. A total of 21 drugs accounted for 90.73% of the annual cost in drugs. Out of 14, only 1 had information of its use in neonatology in all its labels and 9 corresponded to off-label use.

Introducción. El objetivo de este trabajo fue analizar la cantidad de medicamentos dispensados por el Servicio de Farmacia al Servicio de Neonatología, indagar si el uso de estos medicamentos en neonatología está descrito en los prospectos autorizados por la Administración Nacional de Medicamentos, Alimentos, y Tecnología Médica (ANMAT) y comparar esa información con la brindada por Sociedades y Comisiones Médicas. Población y métodos. Estudio analítico, observacional y retrospectivo, en que se analizaron los fármacos en unidades posológicas, costos e importancia en el presupuesto anual 2011. Se analizó la información contenida en los prospectos aprobados por la ANMAT, en el Vademécum Neonatal de la Sociedad Argentina de Pediatría y en los Formularios de la Confederación Médica Argentina y de la Comisión Nacional del Medicamento. Resultados. Durante 2011 se dispensaron 102 medicamentos (91 fármacos). Los suministrados con más frecuencia fueron: antiinfecciosos de uso sistémico (24,51%), medicamentos para sangre y órganos hematopoyéticos, sistema cardiovascular y sistema nervioso (12,72% cada uno). El gasto total fue de 263 285,52 pesos. Sólo 21 medicamentos representaron el 90,73% del costo. De 14 medicamentos de este grupo, 1 tenía información sobre neonatología en todos sus prospectos, 4 solo en alguna de sus presentaciones y en 9 no se mencionaba. El Vademécum Neonatal informaba sobre 12/14 medicamentos, mientras que los Formularios contenían 9/14. Conclusiones. Los medicamentos más usados fueron los antiinfecciosos sistémicos. Veintiún medicamentos representaron el 90,73% del costo anual en fármacos. De 14 de ellos, solo 1 tenía información en todos los prospectos para su uso en neonatología y 9 se utilizaron sin licencia.

Concomitant prescribing and dispensing errors at a Brazilian hospital: a descriptive study

OBJECTIVE: To analyze the prevalence and types of prescribing and dispensing errors occurring with high-alert medications and to propose preventive measures to avoid errors with these medications. INTRODUCTION: The prevalence of adverse events in health care has increased, and medication errors are probably the most common cause of these events. Pediatric patients are known to be a high-risk group and are an important target in medication error prevention. METHODS: Observers collected data on prescribing and dispensing errors occurring with high-alert medications for pediatric inpatients in a university hospital. In addition to classifying the types of error that occurred, we identified cases of concomitant prescribing and dispensing errors. RESULTS: One or more prescribing errors, totaling 1,632 errors, were found in 632 (89.6 percent) of the 705 high-alert medications that were prescribed and dispensed. We also identified at least one dispensing error in each high-alert medication dispensed, totaling 1,707 errors. Among these dispensing errors, 723 (42.4 percent) content errors occurred concomitantly with the prescribing errors. A subset of dispensing errors may have occurred because of poor prescription quality. The observed concomitancy should be examined carefully because improvements in the prescribing process could potentially prevent these problems. CONCLUSION: The system of drug prescribing and dispensing at the hospital investigated in this study should be improved by incorporating the best practices of medication safety and preventing medication errors. High-alert medications may be used as triggers for improving the safety of the drug-utilization system.

Prescription errors in Brazilian hospitals: a multi-centre exploratory survey / Erros de prescrição em hospitais brasileiros: um estudo exploratório multicêntrico

In Brazil, millions of prescriptions do not follow the legal requirements necessary to guarantee the correct dispensing and administration of medication. This multi-centre exploratory study aimed to analyze the appropriateness of prescriptions at four Brazilian hospitals and to identify possible errors caused by inadequacies. The sample consisted of 864 prescriptions obtained at hospital medical clinics in January 2003. Data was collected by three nurse researchers during one week using a standard data sheet that included items about: the type of prescription; legibility; completeness; use of abbreviations; existence of changes and erasures. There were statistically significant differences between incomplete electronic prescriptions at hospital A, and handwritten ones from hospitals C (Ç2 = 12.703 and p < 0.001) and D (Ç2 = 14.074 and p < 0.001). Abbreviations were used in more than 80 percent of prescriptions at hospitals B, C and D. Changes were found in prescriptions at all hospitals, with higher levels at hospitals B (35.2 percent) and A (25.3 percent). This study identified a range of vulnerable points in the prescription phase of the medication system at the hospitals. Physicians, pharmacists and nurses should therefore jointly propose strategies to avoid these prescription errors.

No Brasil, milhões de prescrições não apresentam os requisitos legais necessários para garantir a correta dispensação e administração dos medicamentos. Este estudo multicêntrico exploratório objetivou analisar a adequação das prescrições em quatro hospitais brasileiros e identificar eventuais erros causados pelas inadequações. A amostra consistiu de 864 prescrições obtidas nas clínicas médicas dos hospitais em janeiro de 2003. Os dados foram coletados por três enfermeiras durante uma semana através de instrumento estruturado com variáveis sobre: tipo de prescrição; legibilidade; completude; presença de abreviações, alterações e rasuras. Houve diferenças estatisticamente significativas entre prescrição eletrônica no hospital A e manuscritas nos C (Ç2 = 12,703 e p < 0,001) e D (Ç2 = 14,074 e p < 0,001). Abreviações foram usadas em mais de 80 por cento das receitas nos hospitais B, C e D. Alterações foram encontradas em prescrições de todos os hospitais, com níveis mais elevados no B (35,2 por cento) e A (25,3 por cento). Este estudo identificou uma série de pontos vulneráveis na fase prescrição dos sistemas de medicação dos hospitais. Portanto, médicos, farmacêuticos e enfermeiros deverão juntos propor estratégias para evitar erros de prescrição.

Medication dispensing errors at a public pediatric hospital / Errores de despacho de medicamentos en un hospital público pediátrico / Erros de dispensação de medicamentos em um hospital público pediátrico

OBJECTIVE: assess the safety of medication dispensing processes through the dispensing error rate. METHOD: Cross-sectional study carried out at a pharmaceutical service of a pediatric hospital in Espírito Santo, Brazil. Data collection was performed between August and September 2006, totaling 2620 prescribed medication doses. Any deviation from the medical prescription in dispensing medication was considered a dispensing error. THE CATEGORIES OF MEDICATION ERRORS WERE: content, labeling, and documentation errors. The dispensing error rate was computed by dividing the number of errors by the total of dispensed doses. RESULTS: From the 300 identified errors, 262 (87.3 percent) were content errors. The rate of errors in the labeling and documentation categories was 33 (11 percent) and 5 (1.7 percent), respectively. CONCLUSION: The total dispensing error rate was higher than rates reported in international studies. The most frequent category was "content error".

OBJETIVO: Evaluar la seguridad en el despacho de medicamentos a través de la determinación de la tasa de errores de despacho. MÉTODOS: Estudio transversal que evaluó 2620 dosis de medicamentos despachados entre agosto y septiembre de 2006 en un servicio de farmacia de un hospital pediátrico del Estado de Espíritu Santo, Brasil. Los errores de despacho fueron definidos como cualquier desvío ocurrido entre lo despachado y lo prescrito en la receta médica. Los errores fueron categorizados en contenido, rótulo y documentación. La tasa de error de despacho fue calculada dividiendo el número de errores total por el número total de dosis despachadas. RESULTADOS: de los 300 errores identificados, 262 (87,3 por ciento) fueron de contenido. En las categorías errores de rótulo la tasa fue de 33 (11 por ciento) y 5 (1.7 por ciento) en la de errores de documentación. CONCLUSIÓN: la tasa total de errores de despacho fue elevada cuando se compara con la descrita en estudios internacionales. La categoría de error más frecuente fue la de "error de contenido".

Avaliar a segurança na dispensação de medicamentos através da determinação da taxa de erros de dispensação constituiu o objetivo deste trabalho. O método utilizado foi o estudo transversal que avaliou 2 620 doses de medicamentos dispensados entre agosto e setembro de 2006, em um serviço de farmácia de um hospital pediátrico do Espírito Santo. Os erros de dispensação foram definidos como qualquer desvio entre o dispensado e o prescrito na receita médica. Os erros foram categorizados em conteúdo, rotulagem e documentação. A taxa de erro de dispensação foi calculada dividindo o número de erros total/total de doses dispensadas. Os resultados mostraram que, dos 300 erros identificados, 262 (87,3 por cento) foram de conteúdo. Nas categorias erros de rotulagem a taxa foi de 33 (11 por cento) e 5 (1,7 por cento) na de erros de documentação. Concluiu-se que a taxa total de erros de dispensação foi elevada quando comparada à descrita em estudos internacionais. A categoria de erro mais freqüente foi a de erro de conteúdo.

Drug-dispensing errors in the hospital pharmacy

OBJECTIVE: To determine the dispensing error rate and to identify factors associated with them, and to propose prevention actions. METHODS: A cross-sectional study focusing on the occurrence of dispensing errors in a general hospital in Belo Horizonte that uses a mixed system (a combination of multidose and unit dose systems) of collective and individualized dosing. RESULTS: A total of 422 prescription order forms were analyzed, registering 81.8 percent with at least 1 dispensing error. Opportunities for errors were higher in the pretyped prescription order forms (odds ratio = 4.5; P <.001), in those with 9 or more drugs (odds ratio = 4.0; P <.001), and with those for injectable drugs (odds ratio = 5.0; P <.001). One of the teams of professionals had a higher chance of errors (odds ratio = 2.0; P =.02). A multivariate analysis ratified these results. CONCLUSIONS: The dispensing system at the pharmacy can produce many latent failures and does not have an adequate control; it has several conditions that predispose it to the occurrence of errors, contributing to the high rate reported.

OBJETIVO: Determinar a taxa de erros de dispensação e identificar fatores associados, propondo ações de prevenção. MÉTODOS: Estudo transversal investigou-se a ocorrência de erros de dispensação em um hospital geral de Belo Horizonte que emprega um sistema misto de dose coletiva e individualizada. RESULTADOS: Foram analisadas 422 prescrições, registrando em 81,8 por cento destas pelo menos um erro de dispensação. Oportunidades de erros foram maiores nas prescrições pré-digitadas (Odds Ratio=4,5; p<0,001), naquelas com nove ou mais medicamentos (Odds Ratio=4,0; p<0,001) e com os injetáveis (Odds Ratio=5,0; p<0,001). Uma das equipes de profissionais apresentou maior chance de erros (Odds Ratio=2,0; p=0,02). A análise multivariada ratifica estes resultados. CONCLUSÃO: Conclui-se que o sistema de dispensação da farmácia apresenta muitas falhas latentes e poucas defesas, com diversas condições que predispõe a ocorrência de erros, contribuindo para a elevada taxa registrada.

A study on rational drug prescribing and dispensing in outpatients in a tertiary care teaching hospital of Western Nepal.

OBJECTIVES: To analyze the prescriptions of out-patients for rational prescribing and dispensing and to evaluate the patient's knowledge regarding use of drugs, using INRUD indicators. METHODS: A cross-sectional, descriptive study was conducted at the Manipal Teaching Hospital, Pokhara, Nepal during the time period from June 10th to August 19th 2004. RESULTS: Totally 247 prescriptions were randomly selected for analysis, wherein 720 drugs were prescribed. Only 15% of drugs were prescribed by generic name, 21.67% of the total drugs consisted of fixed-dose combinations, only 40% of drugs were from the Essential drug list of Nepal and 29.44% (n=212) were from the WHO Essential drug list. It was found that more than half (54.17%) of the drugs were from Nepalese National Formulary and 35.69% were from WHO model formulary. Dermatological products were most commonly prescribed followed by drugs acting on central nervous system, antimicrobials and drugs acting on cardiovascular system. Among the drugs dispensed, 79.16% were oral followed by topical (18.19%) and parenteral forms (2.98%). Diagnosis was mentioned only in 3.23% (n=8) of the prescriptions and the average cost per prescription was found to be 241.11 Nepalese rupees (US$ 3.26). It was found out that pharmacist labelled only 0.4% of the medication envelopes with the name of the patient. However, 82.6% of the medication envelopes were labelled with name of the drug and 87.0% with drug strength. Only 53.8% (n=133) of the patient knew both the duration of the therapy and administration time of drugs. CONCLUSION: There is a need for educational intervention for prescribers and both managerial and educational intervention for the hospital pharmacists to improve prescribing and dispensing.